Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

BACKGROUND: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided greater cardiovascular risk red...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://ncbi.nlm.nih.gov/pubmed/29301757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006940
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky